Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

BioRegenx stock

BRGX
US31772N1000
A14PEX

Price

0.01
Today +/-
+0.00
Today %
+5.69 %
P

BioRegenx stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the BioRegenx stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the BioRegenx stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the BioRegenx stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze BioRegenx's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

BioRegenx Stock Price History

DateBioRegenx Price
11/12/20240.01 undefined
11/11/20240.01 undefined
11/8/20240.01 undefined
11/7/20240.01 undefined
10/31/20240.01 undefined
10/30/20240.01 undefined
10/29/20240.02 undefined
10/28/20240.01 undefined
10/24/20240.02 undefined
10/23/20240.01 undefined
10/22/20240.01 undefined
10/21/20240.02 undefined
10/18/20240.01 undefined

BioRegenx Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into BioRegenx, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by BioRegenx from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects BioRegenx’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of BioRegenx. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into BioRegenx’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing BioRegenx’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on BioRegenx’s growth potential.

BioRegenx Revenue, EBIT and net profit per share

DateBioRegenx RevenueBioRegenx EBITBioRegenx Net Income
202322,240 undefined-109,670 undefined-571,170 undefined
202240,000 undefined-80,000 undefined-80,000 undefined
2021200,000 undefined-170,000 undefined-100,000 undefined
2020400,000 undefined-210,000 undefined-270,000 undefined
20040 undefined-220,000 undefined-220,000 undefined
20030 undefined-450,000 undefined-450,000 undefined
20020 undefined-290,000 undefined-290,000 undefined
20010 undefined0 undefined-180,000 undefined
20000 undefined0 undefined-50,000 undefined
199950,000 undefined-70,000 undefined-70,000 undefined
19980 undefined-10,000 undefined-10,000 undefined

BioRegenx Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19981999200020012002200320042020202120222023
00000000000
-----------
-----------
00000000000
00000000000
-----------
000000.010.02267.96269.75269.75276.37
-----------
Details

Keystats

ⓘ

Revenue and Growth

The BioRegenx Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the BioRegenx is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (k)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (k)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (M)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (k)TOTAL ASSETS (k)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (k)LIABILITIES (k)PROVISIONS (M)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (k)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (k)DEBT (k)TOTAL CAPITAL (k)
19981999200020012002200320042020202120222023
                     
0100100050902000
00000000000
00000000000
00000000000
00000000000
0100100050902000
00000000000
0000008023060200.1
00000000000
000000050404031.54
00000000000
00000000000
000000802801006031.64
010010001303701206031.64
                     
101000010100280280280286.65
0.020.140.180.250.50.91.262.442.442.443
-0.01-0.08-0.13-0.31-0.6-1.06-1.28-2.54-2.8-2.92-3.51
-0.010000000000
00000000000
107050-60-100-15080180-80-200-221.97
001040701202030102028.24
00000000000
000000010000
00370404040300000
00000000050225.37
003808011016050401070253.61
00000001502002000
00000000000
00000000000
00000001502002000
003808011016050190210270253.61
10704302010101303701307031.64
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of BioRegenx provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand BioRegenx's financial health and stability.

Assets

BioRegenx's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that BioRegenx must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of BioRegenx after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into BioRegenx's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)

BioRegenx stock margins

The BioRegenx margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BioRegenx. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BioRegenx.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the BioRegenx's sales revenue. A higher gross margin percentage indicates that the BioRegenx retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the BioRegenx's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the BioRegenx's total revenue generated. When comparing the revenue margin year over year, investors can gauge the BioRegenx's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the BioRegenx. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the BioRegenx's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

BioRegenx Margin History

BioRegenx Gross marginBioRegenx Profit marginBioRegenx EBIT marginBioRegenx Profit margin
202396.85 %-493.12 %-2,568.21 %
202275 %-200 %-200 %
202145 %-85 %-50 %
202080 %-52.5 %-67.5 %
200496.85 %0 %0 %
200396.85 %0 %0 %
200296.85 %0 %0 %
200196.85 %0 %0 %
200096.85 %0 %0 %
199996.85 %-140 %-140 %
199896.85 %0 %0 %

BioRegenx Stock Sales Revenue, EBIT, Earnings per Share

The BioRegenx earnings per share therefore indicates how much revenue BioRegenx has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue BioRegenx earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates BioRegenx's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of BioRegenx’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating BioRegenx's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

BioRegenx Revenue, EBIT and net profit per share

DateBioRegenx Sales per ShareBioRegenx EBIT per shareBioRegenx Earnings per Share
20230 undefined-0 undefined-0 undefined
20220 undefined-0 undefined-0 undefined
20210 undefined-0 undefined-0 undefined
20200 undefined-0 undefined-0 undefined
20040 undefined-11 undefined-11 undefined
20030 undefined-45 undefined-45 undefined
20020 undefined0 undefined0 undefined
20010 undefined0 undefined0 undefined
20000 undefined0 undefined0 undefined
19990 undefined0 undefined0 undefined
19980 undefined0 undefined0 undefined

BioRegenx business model

Findit Inc is a company that was founded in 1998 and is headquartered in Atlanta, Georgia. It specializes in providing online marketing and social media solutions. Findit Inc is a publicly traded company and is listed on the OTC market under the symbol FDIT. BioRegenx is one of the most popular companies on Eulerpool.com.

BioRegenx SWOT Analysis

Strengths

Findit Inc has a strong brand reputation in the industry, which enhances its credibility and customer trust.

The company offers a unique and innovative platform that allows users to search and discover various types of content.

Findit Inc has a dedicated and skilled workforce, ensuring efficient operations and prompt customer service.

Weaknesses

The company has limited financial resources, which could restrict its capabilities for expansion and marketing efforts.

Findit Inc heavily relies on a few key clients for a significant portion of its revenue, creating a potential risk if these clients reduce their usage or terminate contracts.

The company's platform may face competition from larger and more established tech companies in the future.

Opportunities

The increasing adoption of social media and content sharing platforms presents an opportunity for Findit Inc to attract a wider user base.

Expansion into international markets can help Findit Inc reach a global audience and diversify its revenue streams.

Continued advancements in technology provide an opportunity for Findit Inc to enhance its platform and offer new features and services.

Threats

The constantly evolving regulatory landscape related to internet content and data privacy poses a threat to Findit Inc's operations and compliance efforts.

Intense competition from other social media and content platforms could lead to reduced market share and user engagement for Findit Inc.

Changes in user preferences and behavior towards content consumption and sharing may impact the demand for Findit Inc's platform.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

BioRegenx Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

BioRegenx historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

BioRegenx shares outstanding

The number of shares was BioRegenx in 2023 — This indicates how many shares 276.367 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue BioRegenx earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates BioRegenx's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of BioRegenx’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating BioRegenx's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for BioRegenx.

BioRegenx shareholders

%
Name
Stocks
Change
Date
20.68570 % Wilshire Holdings Trust197,864,944197,864,9444/29/2024
19.59662 % RNL Lonepeak Holdings, LLC187,447,552187,447,5524/11/2024
12.81921 % Hans Vink Beheer BV122,619,600122,619,6004/11/2024
8.86530 % Libertas Trust84,799,26484,799,2644/29/2024
7.71539 % JARA Trust73,800,00073,800,0004/29/2024
2.16135 % Resides (William R)20,674,00004/29/2024
0.97745 % Kiss (Gary)9,349,56804/11/2024
0.78117 % Bird (Joseph S Jr.)7,472,1001004/29/2024
0.62783 % Powers (Thomas)6,005,400-1,022,0004/11/2024
0.48195 % Hennerberg (Gary)4,610,000-11,826,0004/11/2024
1
2

BioRegenx Executives and Management Board

Darrell Figg
BioRegenx President, Chief Operating Officer, Director
Compensation 15,000
Oso Neal
BioRegenx Interim Chief Executive Officer
John Spicer
BioRegenx Treasurer, Secretary, Director (since 2005)
Todd Davis
BioRegenx Director
1

Most common questions regarding BioRegenx

What values and corporate philosophy does BioRegenx represent?

Findit Inc represents a strong set of values and corporate philosophy. As a company, Findit Inc prioritizes innovation, integrity, and customer satisfaction. They strive to continuously develop groundbreaking solutions for their clients, ensuring their success in the digital landscape. Findit Inc believes in transparent, ethical business practices, acting with honesty and integrity in all their interactions. They are committed to providing exceptional products and services that help businesses effectively market themselves online. Through their dedication to excellence and customer-centric approach, Findit Inc aims to establish long-lasting partnerships and contribute to the success of their clients.

In which countries and regions is BioRegenx primarily present?

Findit Inc is primarily present in the United States.

What significant milestones has the company BioRegenx achieved?

Findit Inc has achieved several significant milestones throughout its history. Notably, the company introduced and developed the Findit platform, a social media content management system that provides individuals and businesses with a unique platform to share and promote their content. Findit Inc has also established various partnerships and collaborations, further expanding its reach and impact in the digital marketing industry. Additionally, the company has successfully enhanced its search engine capabilities, allowing users to easily discover and share content across different online channels. With its continuous efforts and innovative solutions, Findit Inc remains dedicated to empowering users and helping them maximize their online presence.

What is the history and background of the company BioRegenx?

Findit Inc. is a renowned company specializing in online marketing solutions. Established in 1998, Findit has evolved into a leading provider of search engine optimization services, social media management, and content creation. With a strong focus on helping businesses grow their online presence, Findit offers a comprehensive suite of tools and strategies to enhance visibility and drive organic traffic. Over the years, Findit Inc. has garnered a solid reputation for delivering effective online marketing solutions and has established itself as a trusted name in the industry. With a wealth of experience and expertise, Findit Inc. continues to empower businesses to succeed in the competitive digital landscape.

Who are the main competitors of BioRegenx in the market?

The main competitors of Findit Inc in the market include social media platforms like Facebook, Twitter, and Instagram. These platforms also offer users the ability to share and discover content, connect with friends and followers, and promote their businesses. However, Findit Inc differentiates itself by providing a unique platform that focuses on enhancing online visibility for businesses, individuals, and content creators. With its comprehensive features and focus on search engine optimization (SEO), Findit Inc offers a distinct advantage to users who want to increase their online presence and reach a wider audience.

In which industries is BioRegenx primarily active?

Findit Inc is primarily active in the technology and digital advertising industries.

What is the business model of BioRegenx?

Findit Inc. operates as a social media marketing platform, providing online marketing solutions for businesses. Their business model revolves around offering customized online marketing campaigns to help companies increase their online presence and reach their target audience. Leveraging various tools and technologies, Findit Inc. aims to enhance brand visibility, generate leads, and improve search engine rankings for businesses across different industries. By focusing on effective content marketing, social sharing, and search engine optimization strategies, Findit Inc. helps businesses gain exposure, attract new customers, and ultimately drive sales.

What is the P/E ratio of BioRegenx 2024?

The P/E ratio cannot be calculated for BioRegenx at the moment.

What is the P/S ratio of BioRegenx 2024?

The P/S cannot be calculated for BioRegenx currently.

What is the Quality Investing of BioRegenx?

The Quality Investing for BioRegenx is 5/10.

What is the revenue of BioRegenx 2024?

The revenue cannot currently be calculated for BioRegenx.

How high is the profit of BioRegenx 2024?

The profit cannot currently be calculated for BioRegenx.

What is the business model of BioRegenx

Findit Inc is an innovative company that specializes in developing online marketing solutions for businesses and individuals. Its business model goes beyond simply providing advertising space and offers a variety of services and products to its customers. The main products of Findit are Findit Prime and Findit Premium. These products provide unique opportunities for businesses and customers in online marketing. Findit Prime offers businesses the opportunity to enhance their online presence by providing them with a platform for hosting content. The focus of Findit Prime is on SEO-optimized posts that can be read by a wide audience. Findit Premium offers comprehensive online marketing opportunities to its customers, from SEO-optimized posts to social media campaigns. Findit Premium is typically designed for businesses that require a more comprehensive marketing strategy. Findit Inc also offers a range of paid and free products to help its customers take their online presence and marketing to the next level. Findit Health and Wellness, Findit.com, and Gaylord Security are just some of the services that Findit offers. These services provide businesses with the opportunity to enhance their online presence by engaging in targeted content marketing, placing targeted advertisements, and reaching their customers more effectively. With Findit.com, Findit Inc. has an online network that already has a massive reach and is visited by thousands of users every month. The network provides businesses and customers with a platform for creating and sharing content. Findit.com is also a valuable tool for creating backlinks, which can help businesses improve their online presence. In addition, Findit also offers a white-label solution for businesses that want to offer their customers their own online marketing platform. Clients of Findit can use their own branding on the platform, thus maintaining their brand identity. In addition to online marketing services, Findit Inc. also provides services for the real estate industry. Using the latest technologies, Findit delivers unique solutions for real estate agents' marketing needs. This includes online property listings, marketing properties on social media, and placing targeted ads on advertising networks. The business model of Findit Inc. is simple and well-structured: with a wide range of online marketing solutions and products tailored to the specific needs of businesses of various sizes, Findit supports its customers in reaching a broader audience and taking their marketing to a higher level.

What is the BioRegenx dividend?

BioRegenx pays a dividend of 0 USD distributed over payouts per year.

How often does BioRegenx pay dividends?

The dividend cannot currently be calculated for BioRegenx or the company does not pay out a dividend.

What is the BioRegenx ISIN?

The ISIN of BioRegenx is US31772N1000.

What is the BioRegenx WKN?

The WKN of BioRegenx is A14PEX.

What is the BioRegenx ticker?

The ticker of BioRegenx is BRGX.

How much dividend does BioRegenx pay?

Over the past 12 months, BioRegenx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioRegenx is expected to pay a dividend of 0 USD.

What is the dividend yield of BioRegenx?

The current dividend yield of BioRegenx is .

When does BioRegenx pay dividends?

BioRegenx pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioRegenx?

BioRegenx paid dividends every year for the past 0 years.

What is the dividend of BioRegenx?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioRegenx located?

BioRegenx is assigned to the 'Communication' sector.

Wann musste ich die Aktien von BioRegenx kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioRegenx from 11/14/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/14/2024.

When did BioRegenx pay the last dividend?

The last dividend was paid out on 11/14/2024.

What was the dividend of BioRegenx in the year 2023?

In the year 2023, BioRegenx distributed 0 USD as dividends.

In which currency does BioRegenx pay out the dividend?

The dividends of BioRegenx are distributed in USD.

All fundamentals about BioRegenx

Our stock analysis for BioRegenx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioRegenx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.